LXRX Q2 2020 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-5.4% YoY

Gross Profit

$8M92.1% margin

Operating Income

-$65M-704.8% margin

Net Income

-$69M-753.8% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

+14.6%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$323M

Total Liabilities

$333M

Stockholders' Equity

-$11M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$10M	-5.4%
Gross Profit	$8M	$8M	+1.0%
Operating Income	-$65M	-$19M	-248.2%
Net Income	-$69M	-$23M	-200.1%